Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what (a) assessment he has made and (b) research his Department has commissioned on the potential impact of Parkinson’s Disease on the (i) NHS, (ii) social care and (iii) the economy in (A) 2025 and (B) the future.

There are a number of initiatives at the national level supporting service improvement and better care for patients with Parkinson’s disease, including the RightCare Progressive Neurological Conditions Toolkit and the Getting It Right First Time Programme for Neurology.

NHS England has also established a Neurology Transformation Programme, a multi-year, clinically led programme, which has developed a new model of integrated care for neurology services, to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions. A toolkit is being developed to support ICBs to understand and implement this new model, which will include components on delivering acute neurology services, improving health equity in neurology and improving community neurology services.

We have set up a United Kingdom-wide Neuro Forum, facilitating formal, biannual meetings across the Department, NHS England, devolved governments and health services, and Neurological Alliances of all four nations. The new forum brings key stakeholders together, to share learnings across the system and discuss challenges, best practice examples and potential solutions for improving the care of people with neurological conditions, including Parkinson’s disease.

The Government is strongly committed to supporting research into Parkinson’s disease to support prevention, diagnosis, treatment and care. The Department, through the National Institute for Health and Care Research (NIHR), is investing £6 million in two Dementia & Neurodegeneration Policy Research Units to increase evidence and inform policymaking in the Department and its arms-length bodies, including for Parkinson’s disease. This includes research exploring the impact of place, ethnicity and socio-demographic characteristics on health service utilisation by people with Parkinson’s and how health and social care services can best support people living alone with Parkinson’s.

The NIHR welcomes funding applications for research into any aspect of human health and care, including Parkinson’s disease. These applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality.